Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes

被引:75
作者
Gervaise, N
Garrigue, MA
Lasfargues, G
Lecomte, P
机构
[1] CHU Bretonneau, Endocrine Unit, F-37044 Tours, France
[2] CHU Bretonneau, Biochem Lab, F-37044 Tours, France
关键词
Type II diabetes; triglycerides; apolipoprotein C3; lipoprotein B : C3; cardiovascular risk; macroangiopathy; CHD;
D O I
10.1007/s001250051366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Cardiovascular complications and particularly coronary heart disease are the main causes of morbidity and mortality in Type II (non-insulin-dependent) diabetes mellitus. Some studies have shown that hypertriglyceridaemia in diabetes is an independent cardiovascular risk factor. In the ECTIM study high apolipoprotein C3 and lipoprotein B:C3 concentrations (lipoparticles playing a role in triglyceride metabolism) were associated with myocardial infarction in non-diabetic subjects. Methods. We studied the relations between macroangiopathy and different cardiovascular risk factors and lipid variables in 188 Type II diabetic subjects. Results. Multivariate analysis showed that triglycerides, apo C3 and Lp B:C3, sex, duration of diabetes, microalbuminuria and age were independently associated with macroangiopathy. The study group was divided into quartiles according to apo C3 and Lp B:C3 concentrations: the prevalence of macroangiopathy and coronary heart disease were increased in upper quartiles. Conclusion/interpretation. Triglycerides apo C3 and Lp B:C3 were independent cardiovascular risk markers in our group of Type II diabetic patients.
引用
收藏
页码:703 / 708
页数:6
相关论文
共 34 条
[11]   APOLIPOPROTEIN-B METABOLISM IN SUBJECTS WITH DEFICIENCY OF APOLIPOPROTEINS-CIII AND APOLIPOPROTEIN-A-I - EVIDENCE THAT APOLIPOPROTEIN-CIII INHIBITS CATABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS BY LIPOPROTEIN-LIPASE INVIVO [J].
GINSBERG, HN ;
LE, NA ;
GOLDBERG, IJ ;
GIBSON, JC ;
RUBINSTEIN, A ;
WANGIVERSON, P ;
NORUM, R ;
BROWN, WV .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1287-1295
[13]   LIPOPROTEIN PHYSIOLOGY IN NONDIABETIC AND DIABETIC STATES - RELATIONSHIP TO ATHEROGENESIS [J].
GINSBERG, HN .
DIABETES CARE, 1991, 14 (09) :839-855
[14]   TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH LIPOPROTEINS HAVE A DIFFERENTIAL EFFECT ON MILD/MODERATE AND SEVERE LESION PROGRESSION AS ASSESSED BY QUANTITATIVE CORONARY ANGIOGRAPHY IN A CONTROLLED TRIAL OF LOVASTATIN [J].
HODIS, HN ;
MACK, WJ ;
AZEN, SP ;
ALAUPOVIC, P ;
POGODA, JM ;
LABREE, L ;
HEMPHILL, LC ;
KRAMSCH, DM ;
BLANKENHORN, DH .
CIRCULATION, 1994, 90 (01) :42-49
[15]  
HOSNER DW, 1989, WILEY SERIES PROBABI
[16]  
IKEDA T, 1991, DIABETES METAB, V17, P373
[17]   HYPERTRIGLYCERIDEMIA AS A RESULT OF HUMAN APO-CIII GENE-EXPRESSION IN TRANSGENIC MICE [J].
ITO, Y ;
AZROLAN, N ;
OCONNELL, A ;
WALSH, A ;
BRESLOW, JL .
SCIENCE, 1990, 249 (4970) :790-793
[18]   LIPIDS, DIABETES, AND CORONARY HEART-DISEASE - INSIGHTS FROM THE FRAMINGHAM-STUDY [J].
KANNEL, WB .
AMERICAN HEART JOURNAL, 1985, 110 (05) :1100-1107
[19]   DIABETES AND CARDIOVASCULAR-DISEASE - FRAMINGHAM-STUDY [J].
KANNEL, WB ;
MCGEE, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (19) :2035-2038
[20]   CORONARY HEART-DISEASE INCIDENCE IN NIDDM PATIENTS IN THE HELSINKI HEART-STUDY [J].
KOSKINEN, P ;
MANTTARI, M ;
MANNINEN, V ;
HUTTUNEN, JK ;
HEINONEN, OP ;
FRICK, MH .
DIABETES CARE, 1992, 15 (07) :820-825